Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Stérimar Baby is an isotonic seawater nasal spray designed for daily nasal hygiene and the relief of nasal congestion in infants and babies from birth to three years of age. Distributed by Actor Pharma in South Africa, the product contains natural seawater that mechanically cleanses and hydrates the nasal mucosa. Its physical action helps clear mucus, allergens, and impurities from the nasal passages, facilitating easier breathing and feeding. As a medical device, it lacks a specific biological target and works through mechanical irrigation and hydration of the nasal cavity, providing relief from symptoms associated with the common cold, allergic rhinitis, and sinusitis. The product features a specially designed soft nozzle to ensure gentle application in the delicate noses of infants.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Stérimar Baby.